Deerfield

Investor type Hedge Fund

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 151
Average round size
info
The average size of a deal this fund participated in
$66M
Portfolio companies 128
Rounds per year 5.59
Lead investments 31
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Exits 71
Key employees 15
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

Deerfield is the famous VC, which was founded in 1994. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the New York.

Besides them, we counted 15 critical employees of this fund in our database.

The higher amount of exits for fund were in 2015. When the investment is from Deerfield the average startup value is 500 millions - 1 billion dollars. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 50 - 100 millions dollars. Comparing to the other companies, this Deerfield performs on 20 percentage points more the average number of lead investments. Speaking about the real fund results, this VC is 26 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Deerfield, startups are often financed by New Enterprise Associates, Third Rock Ventures, OrbiMed. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, OrbiMed, T. Rowe Price. In the next rounds fund is usually obtained by Deerfield Capital Management, OrbiMed, Venrock.

Among the most successful fund investment fields, there are Biopharma, Medical. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight AveXis, TESARO, Spark Therapeutics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Deerfield:
Typical Co-investors
Deerfield is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Deerfield:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Adaptec - Data Storage California, Milpitas, United States
British Business Bank England, Sheffield, United Kingdom
Buw Germany, Lower Saxony, Osnabrück
Exodus Communications Japan, Tokyo
Grupo SURA Antioquia, Colombia, Medellín
HP WILD HOLDING AG -
Johnson & Johnson Foundation -
Mandiri Investment Management Singapore Central, Central Region, Singapore
MiH Ventures Delhi, India, New Delhi
Nogle Group -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Frontier Medicines

Artificial Intelligence
Biotechnology
Pharmaceutical
$88M19 Jul 2021 San Francisco, California, United States

Talkspace

Consulting
Health Care
mHealth
Therapeutics
$300M23 Jun 2021 New York, New York, United States

CareMax

Health Care
Medical
$400M09 Jun 2021 Miami, Florida, United States

ADC Therapeutics

Biopharma
Biotechnology
Medical
Therapeutics
$50M17 May 2021 Lausanne, Vaud, Switzerland

Adaptive Phage Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$40M11 May 2021 Bethesda, Maryland, United States

Jaguar Gene Therapy

Biotechnology
$139M13 Apr 2021 Lake Forest, Illinois, United States

Jaguar Gene Therapy

Biotechnology
25 Feb 2021 Lake Forest, Illinois, United States

Pairwise Plants LLC

Agriculture
Food and Beverage
$90M03 Feb 2021 Durham, North Carolina, United States

Neomorph

Biotechnology
Health Care
$109M22 Dec 2020 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Deerfield?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: